“Persistent Supravenous Erythematous Eruption (PSEE): A Scoping Review on an Adverse Effect Related to Docetaxel Infusion”. Research, Society and Development, vol. 11, no. 5, Apr. 2022, p. e21111527974, https://doi.org/10.33448/rsd-v11i5.27974.